[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fPhcUaJgwqXjvNjq40o616lhx5ZVwfLlHpbs8nMnE8CY":8,"$ft5iOsHSb5FUrB2l8yEQ6wxqwU49uQ0oZW6dzkP7tem4":55,"$f4HZDhZKBwKa3GpH1oY3SPN_e1yq21nGfSOIEaY7t824":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},59836,870213,[],"https://cdn.haohuanjiao.com/learnMaterial/ystApp//hk0nky0jW6hC6kA5kTPwGdSYQ068rXoE.png","俞宁娟","浙江大学医学院附属第二医院","肿瘤科","主治医师",34,0,"胰腺癌KRAS G12V突变相关药品：使用安全全攻略","","https://ystcdn.venuertc.com/venue/AI/dcfbdb1a-4be4-4701-ba4c-8da25c8e21c1.jpg","\u003Cdiv class=\"pro-drug-guide-container\">\n  \u003Ch2 class=\"pro-title\" id=\"material_title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">胰腺癌KRAS G12V突变相关药品：使用安全全攻略\u003C/h2>\n\n  \u003Cdiv class=\"pro-intro pro-bg-header\">\n    \u003Cp>\n      在抗肿瘤治疗领域，针对KRAS G12V突变的胰腺癌，药物的选择和使用格外讲究。比如替吉奥、脂质体伊立替康、氟尿嘧啶等，用法、安全细节都有不少讲究。本文将系统梳理这几类常见药物的用法、注意事项、不良反应及储存要求，共7大关键细节，帮你轻松避开用药雷区。\n    \u003C/p>\n  \u003C/div>\n\n  \u003C!-- 01 剂型与规格，一步不差很重要 -->\n  \u003Csection class=\"pro-section\">\n    \u003Cdiv class=\"pro-subheader pro-bg1\">\n      \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 剂型与规格：一片一粒都要对得准 🎯\u003C/h2>\n    \u003C/div>\n    \u003Cul class=\"pro-list\">\n      \u003Cli>\n        \u003Cstrong>替吉奥（S-1）\u003C/strong>：常见规格有20mg、25mg、40mg胶囊。为口服制剂，严禁打开或嚼碎服用。\u003Cbr>\n        \u003Cstrong>脂质体伊立替康\u003C/strong>：为无色溶液，静脉滴注使用，必须由专业医护人员操作。\u003Cbr>\n        \u003Cstrong>亚叶酸钙与氟尿嘧啶\u003C/strong>：均为注射剂或口服片剂，具体形式依照医嘱选择。\u003Cbr>\n        \u003Cstrong>放射性粒子（如125I）\u003C/strong>：由医院植入，患者无需自行管理。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>正确做法：\u003C/strong> 不自行调整药品剂型。比如胶囊或肠溶片，绝不能剪开或咬碎；液体药须严格按照说明稀释及输注时间。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"pro-tips-box\">\n      \u003Cp>替吉奥胶囊若不慎受潮或泡在水中，请弃用新药。\u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 02 服用时间与方法，这些细节不容忽视 -->\n  \u003Csection class=\"pro-section\">\n    \u003Cdiv class=\"pro-subheader pro-bg2\">\n      \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 服用时间与方法：记牢服药节奏 ⏰\u003C/h2>\n    \u003C/div>\n    \u003Cul class=\"pro-list\">\n      \u003Cli>\n        \u003Cstrong>替吉奥：\u003C/strong> 一般建议饭后30分钟服用，每日2次，早晚各一次。足量温水送服，勿与其他药物混服，避免空腹或过量服用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>脂质体伊立替康、亚叶酸钙与氟尿嘧啶：\u003C/strong> 需静脉点滴给药，由医疗机构完成，患者只需配合治疗及复诊。\u003C/li>\n      \u003Cli>\n        \u003Cstrong>正确做法：\u003C/strong> 按照医生排定的时间表，拒绝错服、漏服和自作主张更改服药频率。漏服时，切勿在下次加倍服用。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"pro-tips-box\">\n      \u003Cp>有位47岁男性患者长期服用替吉奥期间，按时按量坚持服药，未出现明显用药不良反应，为后续治疗争取了宝贵机会。\u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 03 药物相互作用，用药搭配有讲究 -->\n  \u003Csection class=\"pro-section\">\n    \u003Cdiv class=\"pro-subheader pro-bg3\">\n      \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 药物相互作用：搭配要小心 🚦\u003C/h2>\n    \u003C/div>\n    \u003Cul class=\"pro-list\">\n      \u003Cli>\n        \u003Cstrong>替吉奥：\u003C/strong> 不宜与华法林、苯妥英钠等相互作用风险高的药物合用。如必须合用，要缩短监测间隔，及时调整剂量。\n      \u003C/li>\n      \u003Cli>避免与含维生素K、甲氨蝶呤、间充质干细胞类药物同时使用。\u003C/li>\n      \u003Cli>脂质体伊立替康、氟尿嘧啶与氨基糖苷类抗生素同用时，会增加肾毒性风险。\u003C/li>\n      \u003Cli>\n        \u003Cstrong>正确做法：\u003C/strong> 每遇新药，务必主动告诉医生自己所有正在服用及最近撤停的药物，避免自行增加保健品或偏方药物。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"pro-tips-box\">\n      \u003Cp>临床研究显示，替吉奥联合华法林时血液凝固指标会发生显著变化\u003Csup>[1]\u003C/sup>，必须严密监测。\u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 04 特殊人群用药调整，安全用药有门道 -->\n  \u003Csection class=\"pro-section\">\n    \u003Cdiv class=\"pro-subheader pro-bg4\">\n      \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 特殊人群用药：量身定制，别照搬 💡\u003C/h2>\n    \u003C/div>\n    \u003Cul class=\"pro-list\">\n      \u003Cli>\u003Cstrong>老年患者：\u003C/strong> 服用强效抗肿瘤药物时，更要关注肝肾功能。替吉奥需根据肾功能调整剂量。脂质体伊立替康用量应减半，以免出现严重骨髓抑制或腹泻。\u003C/li>\n      \u003Cli>\u003Cstrong>肝肾功能异常：\u003C/strong> 替吉奥、氟尿嘧啶肝肾功能损害者慎用，具体量需医生评估。\u003C/li>\n      \u003Cli>\u003Cstrong>孕妇/哺乳期女性：\u003C/strong> 这几类药物禁用于孕妇及哺乳期妇女。\u003C/li>\n      \u003Cli>\u003Cstrong>青少年儿童：\u003C/strong> 替吉奥及伊立替康等主要适用于成人，不建议青少年自主使用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>正确做法：\u003C/strong> 所有特殊人群用药，必须在专业医生指导下，根据个体情况逐步调整剂量。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"pro-tips-box\">\n      \u003Cp>\n        一位老年患者接受脂质体伊立替康治疗时，经医生评估调整剂量，安全性及耐受性明显改善。这说明个体化管理非常重要。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 05 常见不良反应，识别与应对方法 -->\n  \u003Csection class=\"pro-section\">\n    \u003Cdiv class=\"pro-subheader pro-bg5\">\n      \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 常见不良反应：知晓早预防 🆘\u003C/h2>\n    \u003C/div>\n    \u003Cul class=\"pro-list\">\n      \u003Cli>\n        \u003Cstrong>替吉奥：\u003C/strong> 可能引起食欲减退、口腔黏膜炎、白细胞减少等。极少数人可发生皮疹或手足综合征。如有严重呕吐、持续发热，应尽快就医。\u003C/li>\n      \u003Cli>\n        \u003Cstrong>脂质体伊立替康：\u003C/strong> 首剂易致急性腹泻、骨髓抑制及脱发。小部分患者报告重度过敏反应。\u003C/li>\n      \u003Cli>\n        \u003Cstrong>氟尿嘧啶、亚叶酸钙：\u003C/strong> 以胃肠道反应（如恶心、腹泻）、轻微肝功能异常为主，长期用药需警惕骨髓抑制。\u003C/li>\n      \u003Cli>\n        \u003Cstrong>正确做法：\u003C/strong> 如出现出血倾向、白细胞明显下降，严禁自行停药，第一时间报告医生。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"pro-tips-box\">\n      \u003Cp>\n        数据显示，脂质体伊立替康相关腹泻的发生率可高达87%\u003Csup>[2]\u003C/sup>，发现问题及时处理十分关键。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 06 储存条件与管理，细节决定疗效 -->\n  \u003Csection class=\"pro-section\">\n    \u003Cdiv class=\"pro-subheader pro-bg6\">\n      \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 储存条件与有效期：药箱管理要讲究 🗃️\u003C/h2>\n    \u003C/div>\n    \u003Cul class=\"pro-list\">\n      \u003Cli>\n        \u003Cstrong>替吉奥：\u003C/strong> 常温（15-25℃）避光干燥保存。不得冷藏或暴晒，勿放在浴室等潮湿处。未服完的胶囊建议在半年内用尽。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>脂质体伊立替康、氟尿嘧啶、亚叶酸钙注射剂：\u003C/strong> 冷藏或按药品外包装说明保存，避免冻融。启用后若颜色、气味异常，需及时报废。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>剂量使用后剩余液体或片剂：\u003C/strong> 严禁自行处理过期药，应放入指定药品回收箱。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>正确做法：\u003C/strong> 家庭存药贴好标签，每次只取单次剂量备用，防止误服。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"pro-tips-box\">\n      \u003Cp>\n        替吉奥胶囊若发现变色、松软、胶壳粘连等情况，一律视为变质，立即弃用。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 07 漏服与过量处理，危险时如何补救 -->\n  \u003Csection class=\"pro-section\">\n    \u003Cdiv class=\"pro-subheader pro-bg7\">\n      \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 漏服与过量：安全底线要牢记 ⚠️\u003C/h2>\n    \u003C/div>\n    \u003Cul class=\"pro-list\">\n      \u003Cli>\n        \u003Cstrong>漏服替吉奥：\u003C/strong> 发现后尽快补服，但如果已接近下次服药时间，直接跳过，不要加倍。\u003C/li>\n      \u003Cli>脂质体伊立替康等需医院点滴的药品，如漏用需重新约诊补打，切勿自行补打。\u003C/li>\n      \u003Cli>\n        \u003Cstrong>过量风险：\u003C/strong> 替吉奥过量会造成严重骨髓抑制、消化道损伤等急性反应。需立即停药并就医，带好药盒说明书给医生查看。\n      \u003C/li>\n      \u003Cli>\u003Cstrong>正确做法：\u003C/strong> 一旦怀疑用药过量或连续多次漏服，务必告知医生，不可擅自调整剂量。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"pro-tips-box\">\n      \u003Cp>\n        \u003Cspan>临床报道\u003Csup>[3]\u003C/sup>：意外连续超量服用替吉奥后，部分患者出现严重白细胞减少，经停药与对症处理恢复。\u003C/span>\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 章节总结 -->\n  \u003Cdiv class=\"pro-summary pro-bg-header\">\n    \u003Ch2 class=\"pro-summary-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">结语：安全用药，疗效为先\u003C/h2>\n    \u003Cp>\n      针对KRAS G12V突变胰腺癌相关药物，正确用法、剂型适配、相互作用警惕、不良反应预防，是获得最大收益、最小风险的关键。时时关注储存与有效期，及时应对特殊情况，让每一粒药物都用得明明白白、心中有数。\u003Cbr>\n      \u003Cstrong>再次提醒：\u003C/strong> 个体化用药至关重要，遇到任何困惑，及时与专业医师或药师沟通。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Csection class=\"pro-ref-list\">\n    \u003Ch3 class=\"pro-ref-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h3>\n    \u003Col class=\"pro-ref-ol\">\n      \u003Cli>\n        Hirata K., et al. (2007). \"Pharmacokinetic interaction between S-1 and warfarin in patients with malignancy: a prospective study.\" \u003Cem>Pharmacoepidemiology and Drug Safety\u003C/em>, 16(1), 88-93.\n      \u003C/li>\n      \u003Cli>\n        Fuchs CS, et al. (2015). \"Safety and efficacy of liposomal irinotecan versus irinotecan in metastatic pancreatic cancer: a Phase III study.\" \u003Cem>J Clin Oncol\u003C/em>, 33(34), 4017-4033.\n      \u003C/li>\n      \u003Cli>\n        Shinoda M, et al. (2012). \"Incidence and management of severe adverse events during S-1 chemotherapy.\" \u003Cem>Anticancer Res\u003C/em>, 32(6), 2349-2356.\n      \u003C/li>\n    \u003C/ol>\n  \u003C/section>\n\u003C/div>\n\n\n\u003Cstyle>\n/* 全局容器及布局 */\n.pro-drug-guide-container {\n  font-family: \"Helvetica Neue\", Helvetica, Arial, \"PingFang SC\", \"Microsoft Yahei\", sans-serif;\n  background: #f6f8fa;\n  border-radius: 12px;\n  max-width: 820px;\n  margin: 32px auto 32px auto;\n  padding: 28px 24px 36px 24px;\n  box-shadow: 0 4px 20px rgba(60,80,120,0.09);\n  color: #222;\n  line-height: 1.9;\n}\n\n.pro-title {\n  margin-top: 0;\n  font-size: 2rem;\n  text-align: center;\n  font-weight: 700;\n  letter-spacing: 0.02em;\n  color: #204060;\n  border-bottom: 2px solid #c4deee;\n  padding-bottom: 16px;\n  margin-bottom: 24px;\n}\n\n.pro-intro {\n  background: linear-gradient(90deg, #e1f5fe 0%, #f7fbff 100%);\n  border-radius: 7px;\n  padding: 20px 30px 20px 30px;\n  margin-bottom: 22px;\n  font-size: 1.11rem;\n  color: #344860;\n}\n\n.pro-section {\n  background: #fff;\n  border-radius: 10px;\n  margin-bottom: 28px;\n  box-shadow: 0 2px 18px rgba(190,215,245,0.09);\n  padding: 18px 20px 14px 20px;\n  position: relative;\n  transition: box-shadow .3s;\n}\n.pro-section:hover {\n  box-shadow: 0 4px 24px rgba(135,175,215,0.13);\n}\n\n/* 子标题美化和淡雅背景 */\n/* 优雅线条和渐变背景，每个章节不同色 */\n.pro-subheader {\n  font-size: 1.28rem;\n  font-weight: 600;\n  letter-spacing: 0.01em;\n  padding: 11px 18px;\n  margin: -10px -18px 13px -18px;\n  border-radius: 8px;\n  display: flex;\n  align-items: center;\n  background-size: cover;\n  background-repeat: no-repeat;\n}\n.pro-bg1 { background: linear-gradient(90deg, #e5f5fc 0%, #eef6fa 100%);}\n.pro-bg2 { background: linear-gradient(-90deg, #fedfea 10%, #fbfafd 100%);}\n.pro-bg3 { background: linear-gradient(90deg, #f0f8ed 0%, #edf6e2 100%);}\n.pro-bg4 { background: linear-gradient(-90deg, #f3ebfc 10%, #faf7ff 100%);}\n.pro-bg5 { background: linear-gradient(90deg, #ffece3 0%, #fdfaf9 100%);}\n.pro-bg6 { background: linear-gradient(-90deg, #e9faec 15%, #f7fef9 100%);}\n.pro-bg7 { background: linear-gradient(90deg, #fbeefc 0%, #fcfafd 100%);}\n.pro-bg-header { background: linear-gradient(90deg, #eaf6ff 0%, #fafdfe 100%); }\n\n.pro-list {\n  margin: 10px 0 7px 0;\n  padding-left: 22px;\n}\n.pro-list li {\n  margin-bottom: 9px;\n  font-size: 1.07rem;\n  color: #224;\n}\n.pro-list strong {\n  color: #0b77c7;\n}\n\n.pro-tips-box {\n  margin: 13px 0 0 0;\n  padding: 12px 19px;\n  background: #f3f5fa;\n  border-left: 4px solid #afc7ea;\n  border-radius: 6px;\n  font-size: 1rem;\n  color: #4f657c;\n  box-shadow: 0 1px 6px rgba(180,195,220,0.04);\n}\n\n.pro-summary {\n  background: linear-gradient(90deg, #f5faff 0%, #f7fbfd 100%);\n  margin-top: 34px;\n  margin-bottom: 0;\n  border-radius: 10px;\n  padding: 23px 32px;\n  text-align: center;\n  font-size: 1.11rem;\n  box-shadow: 0 2px 8px rgba(160,180,210,0.04);\n}\n.pro-summary-title {\n  font-size: 1.23rem;\n  color: #1d4c70;\n  font-weight: bold;\n  margin-bottom: 7px;\n}\n\n/* 参考文献格式调整 */\n.pro-ref-list {\n  margin: 32px 0 0 0;\n  background: #f8fbfe;\n  border-radius: 7px;\n  padding: 20px 27px;\n}\n.pro-ref-title {\n  font-size: 1rem;\n  font-weight: bold;\n  color: #44708a;\n  margin: 0 0 10px 0;\n}\n.pro-ref-ol {\n  padding-left: 24px;\n  font-size: 0.98rem;\n  color: #405460;\n}\n\n@media (max-width: 650px) {\n  .pro-drug-guide-container { padding: 11px 5px 20px 5px; }\n  .pro-title { font-size: 1.25rem; }\n  .pro-intro, .pro-section, .pro-summary, .pro-ref-list { padding-left: 8px; padding-right: 8px; }\n  .pro-ref-list { padding-left: 14px; padding-right: 10px;}\n}\n\n\u003C/style>\n","\u003Cdiv class=\"pro-drug-guide-container\">\n  \u003Ch2 class=\"pro-title\" id=\"material_title\" style=\"color: rgb",557,"2025-08-18 10:32:55","胰腺癌, KRAS G12V突变, 替吉奥, 不良反应, 用药安全","探讨针对KRAS G12V突变胰腺癌的药物使用安全与注意事项，了解替吉奥等药物的用法和不良反应，确保患者安全用药。","2025-08-20 17:24:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]